Seldon Capital’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.37M Buy
+11,563
New +$4.04M 1.27% 25

Other funds holding BIO

Seldon Capital's BIO Position: Q3 2026 in Review

Seldon Capital opened a new position in Bio-Rad Laboratories Class A (BIO) in Q3 2026: 11,563 shares worth $4.37M. The stake represents 1.27% of the portfolio and ranks #25 among its holdings.

419 funds tracked by Wall St. Rank hold BIO as of Q3 2026.

  • Seldon Capital held 11,563 shares of Bio-Rad Laboratories Class A worth $4.37M as of Q3 2026.
  • Bio-Rad Laboratories Class A was a new Seldon Capital position in Q3 2026.
  • Bio-Rad Laboratories Class A made up 1.27% of Seldon Capital's portfolio in Q3 2026, its #25 holding.
  • 419 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2026.

Based on Seldon Capital's 13F filing for Q3 2026, filed 16 Nov 2026.